Virtus LifeSci Biotech Products ETF
13 hedge funds and large institutions have $6.14M invested in Virtus LifeSci Biotech Products ETF in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
13
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$1.39M | |
2 | +$1.34M | |
3 | +$498K | |
4 |
GEA
Glen Eagle Advisors
Kingston,
New Jersey
|
+$2.63K |
Top Sellers
1 | -$1.8M | |
2 | -$136K | |
3 | -$107K | |
4 |
LPL Financial
San Diego,
California
|
-$32K |
5 |
Stifel Financial
St. Louis,
Missouri
|
-$13.3K |